Autopsy report · NCT03342859

Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Due to findings in the preclinical carcinogenicity studies for vilaprisan (BAY1002670)”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 2 years 2 months before it stopped.
10 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Bayer
Sponsor type: Industry
Conditions: Leiomyoma
Interventions: Vilaprisan, BAY1002670; Ulipristal
Participants: 10
Sites: 1
Countries: United Kingdom

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.